The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients
Main Authors: | de Oliveira, Rodrigo Bueno, Liabeuf, Sophie, Okazaki, Hirokazu, Lenglet, Aurelie, Desjardins, Lucie, Lemke, Horst-Dieter, Vanholder, Raymond, Choukroun, Gabriel, Massy, Ziad A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094389/ |
Similar Items
-
Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
by: Desjardins, Lucie, et al.
Published: (2013) -
Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
by: Liabeuf, Sophie, et al.
Published: (2013) -
The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
by: Liabeuf, Sophie, et al.
Published: (2015) -
Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
by: Neirynck, Nathalie, et al.
Published: (2012) -
Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
by: Lenglet, Aurélie, et al.
Published: (2013)